XML 25 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Balance (in shares) at Dec. 31, 2018   88,730,640      
Balance at Dec. 31, 2018 $ 125,370 $ 89 $ 266,882 $ (3,633) $ (137,968)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 46,139   46,139    
Common stock issued under employee stock plans, net (shares)   3,019,293      
Common stock issued under employee stock plans, net (2,397) $ 3 (2,400)    
Realized and unrealized gains (losses) on derivative 3,158     3,158  
Unrealized gains (losses) in available for sale securities 26     26  
Net loss (78,764)       (78,764)
Balance (in shares) at Dec. 31, 2019   91,749,933      
Balance at Dec. 31, 2019 93,532 $ 92 310,621 (449) (216,732)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 68,585   68,585    
Common stock issued under employee stock plans, net (shares)   3,600,003      
Common stock issued under employee stock plans, net 9,791 $ 3 9,788    
Issuance of common stock from acquisitions (in shares)   106,926      
Issuance of common stock from acquisitions 4,198 $ 0 4,198    
Fair value of replacement equity awards attributable to pre-acquisition service 709   709    
Realized and unrealized gains (losses) on derivative 9,838     9,838  
Unrealized gains (losses) in available for sale securities (18)     (18)  
Purchase of capped calls related to Convertible senior notes (29,348)   (29,348)    
Equity component of Convertible senior notes, net 30,794   30,794    
Net loss (94,010)       (94,010)
Balance (in shares) at Dec. 31, 2020   95,456,862      
Balance at Dec. 31, 2020 94,071 $ 95 395,347 9,371 (310,742)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Common stock in connection with follow-on offering, net of issuance costs of $17,466 (in shares)   7,961,538      
Issuance of Common stock in connection with follow-on offering, net of issuance costs of $17,466 500,034 $ 8 500,026    
Stock-based compensation expense 109,779   109,779    
Common stock issued under employee stock plans, net (shares)   4,090,696      
Common stock issued under employee stock plans, net 12,858 $ 5 12,853    
Realized and unrealized gains (losses) on derivative (3,285)     (3,285)  
Unrealized gains (losses) in available for sale securities (3)     (3)  
Net loss (116,861)       (116,861)
Balance (in shares) at Dec. 31, 2021   107,509,096      
Balance at Dec. 31, 2021 $ 596,593 $ 108 $ 1,018,005 $ 6,083 $ (427,603)